| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Common Stock, par value $0.01 per share |
15.9% |
$37.9M |
$1.19M |
30M |
+3.25% |
Rubric Capital Management LP |
Oct 15, 2025 |
| IART |
Integra Lifesciences Holdings Corporation |
Common Stock, par value $0.01 per share |
9.46% |
$97.7M |
$36M |
7.35M |
+58.4% |
Rubric Capital Management LP |
Jun 30, 2025 |
| COLL |
Collegium Pharmaceutical, Inc. |
Common Stock, $0.001 par value |
9.34% |
$78.9M |
$17.1M |
3M |
+27.7% |
Rubric Capital Management LP |
Mar 31, 2025 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
Class A Ordinary Shares, nominal value $0.000273235 per share |
9.24% |
$100M |
$13.5M |
3.91M |
+15.6% |
RUBRIC CAPITAL MANAGEMENT LP |
Jun 30, 2025 |
| ECVT |
Ecovyst Inc. |
Common Stock, par value $0.01 per share |
9.09% |
$91.1M |
|
10.4M |
|
Rubric Capital Management LP |
Sep 30, 2025 |
| NFE |
New Fortress Energy Inc. |
Class A Common Stock, par value $0.01 |
8.89% |
$144M |
$55.1M |
24.3M |
+62.3% |
Rubric Capital Management LP |
Mar 31, 2025 |
| GLNG |
Golar LNG Limited |
Common Shares, $1.00 par value per share |
8.59% |
$315M |
$44.4M |
8.98M |
+16.4% |
Rubric Capital Management LP |
Mar 31, 2025 |
| TLN |
Talen Energy Corporation |
Common Stock, $0.001 par value per share |
7.88% |
$1.53B |
-$384M |
3.6M |
-20% |
David Rosen |
Sep 30, 2025 |
| SDGR |
Schrodinger, Inc. |
Common Stock, $0.01 par value |
7.85% |
$122M |
|
5M |
|
Rubric Capital Management LP |
Dec 31, 2024 |
| TRVI |
Trevi Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
7.12% |
$54.2M |
$27.5M |
8.53M |
+103% |
Rubric Capital Management LP |
Jun 30, 2025 |
| QDEL |
QuidelOrtho Corporation |
Common Stock, par value $0.001 per share |
6.86% |
$169M |
-$33.2M |
4.64M |
-16.4% |
Rubric Capital Management LP |
Jun 30, 2025 |
| OPK |
OPKO Health, Inc. |
Common Stock, par value $0.01 per share |
6.03% |
$62.1M |
|
47.8M |
|
Rubric Capital Management LP |
Jun 30, 2025 |
| TAC |
TransAlta Corporation |
Common Shares, no par value |
5.38% |
$146M |
|
15.9M |
|
Rubric Capital Management LP |
Jun 30, 2025 |
| CHRS |
Coherus BioSciences, Inc. |
Common Stock, $0.0001 par value |
4.56% |
$4.42M |
|
5.26M |
|
Rubric Capital Management LP |
Dec 31, 2024 |
| SEG |
Seaport Entertainment Group Inc. |
Common Stock, par value $0.01 |
4.51% |
$10.2M |
|
573K |
|
Rubric Capital Management LP |
Dec 31, 2024 |
| DOLE |
Dole Plc |
Ordinary Shares, $0.01 par value per share |
4.37% |
$60M |
|
4.16M |
|
Rubric Capital Management LP |
Mar 31, 2025 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common stock, par value $0.0001 per share |
4.12% |
$58.1M |
|
6.26M |
|
Rubric Capital Management LP |
Jun 30, 2025 |
| MD |
Pediatrix Medical Group, Inc. |
Common Stock, $0.01 par value |
3.67% |
$42.5M |
|
3.15M |
|
Rubric Capital Management LP |
Dec 31, 2024 |
| OVID |
Ovid Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0.67% |
$139K |
|
479K |
|
Rubric Capital Management LP |
Jun 30, 2025 |
| GDRX |
GoodRx Holdings, Inc. |
Class A Common Stock, $0.0001 par value |
0% |
$0 |
-$25.6M |
0 |
-100% |
Rubric Capital Management LP |
Mar 31, 2025 |